Showing results (241-250 of 582) with videos related to
Sort By:
Pageof 59
Neurology|October 15, 2008
Update on blepharospasm: report from the BEBRF International WorkshopMark Hallett, Craig Evinger, Joseph Jankovic, et al.Neurotoxicity Research|May 17, 2013
Flu-like symptoms and associated immunological response following therapy with botulinum toxinsJosé Fidel Baizabal-Carvallo, Joseph Jankovic, Jordan FeldTremor and Other Hyperkinetic Movements (New York, N.Y.)|February 27, 2013
Intermediate CAG Repeats in Huntington's Disease: Analysis of COHORTAinhi D Ha, Christopher A Beck, Joseph JankovicMovement Disorders : Official Journal of the Movement Disorder Society|February 5, 2015
The therapeutic potential of cannabinoids for movement disordersBenzi Kluger, Piera Triolo, Wallace Jones, et al.Expert Opinion on Drug Safety|April 8, 2021
Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisalLuca Marsili, Matteo Bologna, Joseph Jankovic, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 7, 2010
Tardive dyskinesia and other movement disorders secondary to aripiprazoleMaria Sierra Peña, Toby C Yaltho, Joseph JankovicMovement Disorders : Official Journal of the Movement Disorder Society|June 30, 2011
Diagnosis and treatment of complications related to deep brain stimulation hardwareJosé Fidel Baizabal Carvallo, Richard Simpson, Joseph JankovicMovement Disorders : Official Journal of the Movement Disorder Society|October 24, 2013
Long-term efficacy and safety of fluphenazine in patients with Tourette syndromeSubhashie Wijemanne, Laura J C Wu, Joseph JankovicJournal of Advanced Research|January 4, 2024
CADASIL: A NOTCH3-associated cerebral small vessel diseaseLamei Yuan, Xiangyu Chen, Joseph Jankovic, et al.Neurobiology of Disease|February 25, 2019
Pathogenesis and pathophysiology of functional (psychogenic) movement disordersJosé Fidel Baizabal-Carvallo, Mark Hallett, Joseph JankovicPageof 59